Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Melinta Therapeutics Inc. buy Quitte

Melinta Therapeutics Inc.
Start price
€19.73
18.09.18 / 50%
Target price
€31.57
29.10.18
Performance (%)
-42.40%
End price
€11.37
29.10.18
Summary
This prediction ended on 29.10.18 with a price of €11.37. Massive losses of -42.40% were the result for the BUY prediction by Quitte. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Melinta Therapeutics Inc. - - - -
iShares Core DAX® 2,55 % -0,11 % 15,00 % 49,60 %
iShares Nasdaq 100 2,74 % -0,47 % 30,95 % 80,87 %
iShares Nikkei 225® 6,58 % 3,22 % 49,70 % 60,37 %
iShares S&P 500 1,93 % -0,52 % 24,88 % 60,00 %

Comments by Quitte for this prediction

In the thread Melinta Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -42.40%
Target price 31.570
Change
Ends at 29.10.18

die kommt

https://www.streetinsider.com/Corporate+News//Melinta+Therapeutics+%28MLNT%29+Names+Peter+Milligan+as+CFO/14617554.html

Quitte 
0
Report Share
18.09.18
Prediction Buy
Perf. (%) -42.40%
Target price 31.570
Change
Ends at 29.10.18

(Vom Mitglied beendet)

Quitte 
0
Report Share
29.10.18

Stopped prediction by Quitte for Melinta Therapeutics Inc.

sell
Melinta Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.44
06.01.20
-
09.01.20
1.35%
09.01.20

Quitte 
06.01.20 50%
buy
Melinta Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.14
07.01.19
€13.53
08.07.19
25.78%
08.07.19

Quitte 
21.08.19 50%
buy
Melinta Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.98
29.10.18
€22.55
07.01.19
-53.18%
07.01.19

Quitte 
21.08.19 50%
buy
Melinta Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.28
18.09.18
€23.45
18.09.18
0.00%
18.09.18

Quitte 
21.08.19 50%
buy
Melinta Therapeutics Inc.

Start price
Target price
Perf. (%)
€64.48
30.12.16
€95.00
28.03.17
52.77%
28.03.17

Quitte 
21.08.19 50%